TABLE OF CONTENTS Volume 6, Number 6, November 2019 Neurology.org/NN

Editor’s Corner

e630 Learning from adverse treatment effectsJ. Dalmau

Open Access

Editorials

e617 Untangling normal aging from disease-related brainatrophy in MST. Sinnecker and J. Wuerfel

Open Access Companion article, p. e616

e629 Pembrolizumab as a treatment for PML? Waitingfor GodotR.A. Du Pasquier

Open Access Companion articles, p. e627 and e628

Articles

e604 Increased frequency of anti-Ma2 encephalitisassociated with immune checkpoint inhibitorsA. Vogrig, M. Fouret, B. Joubert, G. Picard, V. Rogemond, A.-L. Pinto,S. Muñiz‐Castrillo, M. Roger, J. Raimbourg, C. Dayen, L. Grignou,M. Pallix-Guyot, J. Lannoy, F. Ducray, V. Desestret, D. Psimaras, andJ. Honnorat

Open Access

e605 HLA and microtubule-associated protein tau H1haplotype associations in anti-IgLON5 diseaseC. Gaig, G. Ercilla, X. Daura, M. Ezquerra, R. Fernandez-Santiago,E. Palou, L. Sabater, R. Hoftberger, A. Heidbreder, B. Hogl, A. Iranzo,J. Santamaria, J. Dalmau, and F. Graus

Open Access

e607 Late-onset neuromyelitis optica spectrum disorder:The importance of autoantibody serostatusM. Sepulveda, G. Delgado-Garcıa, Y. Blanco, N. Sola-Valls,E.H. Martinez-Lapiscina, T. Armangue, C. Montejo,I. Pulido-Valdeolivas, E. Martinez-Hernandez, H. Ariño, D. Escudero,R. Ruiz-Garcıa, S. Llufriu, J. Dalmau, F. Graus, and A. Saiz

Open Access

e609 Glutamine antagonism attenuates physical andcognitive deficits in a model of MSK.R. Hollinger, M.D. Smith, L.A. Kirby, E. Prchalova, J. Alt, R. Rais,P.A. Calabresi, and B.S. Slusher

Open Access

e612 Neurochondrin neurological autoimmunityS. Shelly, T.J. Kryzer, L. Komorowski, R. Miske, M.D. Anderson,E.P. Flanagan, S.R. Hinson, V.A. Lennon, S.J. Pittock, and A. McKeon

Open Access

e614 Lymphocyte counts and infection rates: Long-termfingolimod treatment in primary progressive MSE.J. Fox, F.D. Lublin, J.S. Wolinsky, J.A. Cohen, I.M. Williams, X. Meng,M. Ziehn, S. Kolodny, and B.A.C. Cree

Open Access Class of Evidence

e615 Peripheral neuropathy in antineutrophil cytoplasmicantibody-associated vasculitides: Insights from theDCVAS studyA. Bischof, V.K. Jaeger, R.D.M. Hadden, R.A. Luqmani, A.-K. Probstel,P.A. Merkel, R. Suppiah, A. Craven, M.P. Collins, and T. Daikeler

Open Access

e616 Contribution of normal aging to brain atrophy in MSC.J.Azevedo,S.Y.Cen,A. Jaberzadeh,L. Zheng,S.L.Hauser,andD.Pelletier

Open Access Editorial, p. e617

e618 Progressive multifocal leukoencephalopathy:A 25-year retrospective cohort studyP. Anand, G.C. Hotan, A. Vogel, N. Venna, and F.J. Mateen

Open Access

e621 Effects of natalizumab therapy on intrathecal antiviralantibody responses in MSF. Largey, I. Jelcic, M. Sospedra, C. Heesen, R. Martin, and I. Jelcic

Open Access

e622 Vitamin D enhances responses to interferon-β in MSX. Feng, Z. Wang, Q. Howlett-Prieto, N. Einhorn, S. Causevic, andA.T. Reder

Open Access

e623 Elevated levels ofmiR-181c andmiR-633 in theCSF ofpatients with MS: A validation studyS. Kramer, A. Haghikia, C. Bang, K. Scherf, A. Pfanne, A. Duscha,J. Kaisler, B. Gisevius, R. Gold, T. Thum, and A. Haghikia

Open Access Class of Evidence

Cover ImageSimilar microbiome profiles in patients with anti-NMDAR encephalitisand control subjects. The figure shows multidimensional scaling plotsof Bray-Curtis distances at genera and Operational Taxonomic Unitslevel, demonstrating a high level of similarity regarding inter-individualdifferences between anti-NMDAR encephalitis patients and healthysubjects.See page e632

Continued

e625 Identification of circulating MOG-specific B cells inpatients with MOG antibodiesS. Winklmeier, M. Schluter, M. Spadaro, F.S. Thaler, A. Vural,R. Gerhards, C. Macrini, S. Mader, A. Kurne, B. Inan, R. Karabudak,F.G. Ozbay, G. Esendagli, R. Hohlfeld, T. Kumpfel, and E. Meinl

Open Access

e626 Classifying the antibody-negative NMO syndromes:Clinical, imaging, and metabolomic modelingT. Yeo, F. Probert,M. Jurynczyk,M. Sealey, A. Cavey, T.D.W. Claridge,M. Woodhall, P. Waters, M.I. Leite, D.C. Anthony, and J. Palace

Open Access

e631 IL6 receptor358Ala variant and trans-signaling aredisease modifiers in amyotrophic lateral sclerosisM. Wosiski-Kuhn, M. Robinson, J. Strupe, P. Arounleut, M. Martin,J. Caress, M. Cartwright, R. Bowser, M. Cudkowicz, C. Langefeld,G.A. Hawkins, and C. Milligan

Open Access

e632 Normal gut microbiome in NMDA receptorencephalitisJ. Herken, C. Bang, M.C. Ruhlemann, C. Finke, J. Klag, A. Franke, andH. Pruss

Open Access

Clinical/Scientific Notes

e606 Steroid-sparing agents for the treatment ofinflammation in complicated neurocysticercosisP. Anand, S.S. Mukerji, J. Thon, S. Gunaratne, T.A. Cho, and N. Venna

Open Access

e608 CNS-disseminated Angiostrongylus cantonensismimicking atypical demyelinating diseaseD. Long, K. Green, T. Derani, N. Decker, R.J. Pace, and R. Aburashed

Open Access

e611 Toll-like receptor 3 deficiency in autoimmuneencephalitis post–herpes simplex encephalitisT. Armangue, B.J. Baucells, A. Vlagea,M. Petit-Pedrol, A. Esteve-Sole,A. Deya-Martınez, R. Ruiz-Garcıa, M. Juan, R. Perez de Diego,J. Dalmau, and L. Alsina

Open Access

e613 CSF orexin-A levels after rituximab treatment inrecent onset narcolepsy type 1P. Wasling, C. Malmestrom, and K. Blennow

Open Access

e619 Expanding the MOG phenotype: Brainstemencephalitis with punctate and curvilinearenhancementS. Matesanz, C. Kotch, C. Perrone, A.J. Waanders, B. Hill, andS. Narula

Open Access

e620 Overnight loss of pigmented hair in autoimmuneautonomic neuropathy treated with IVIgL.E. Turner, S.J. Pittock, M.T. McEvoy, and E.P. Flanagan

Open Access

e624 Fatal PCR-negative herpes simplex virus-1encephalitis with GABAA receptor antibodiesS. Schuster, L. Abrante, J. Matschke, M. Lutgehetmann, B. Holst,M. Gelderblom, H. Braass, F. Leypoldt, and T. Magnus

Open Access

e627 Ineffective treatment of PML with pembrolizumab:Exhausted memory T-cell subsets as a clue?M. Pawlitzki, T. Schneider-Hohendorf, L. Rolfes, S.G. Meuth,H. Wiendl, N. Schwab, and O.M. Grauer

Open Access Editorial, p. e629

e628 Pembrolizumab for progressive multifocalleukoencephalopathy due to primaryimmunodeficiencyC. Kupper, J. Heinrich, K. Kamm, V. Bucklein, S. Rothenfusser, andA. Straube

Open Access Editorial, p. e629

Views & Reviews

e610 Generation of neuroinflammation in human AfricantrypanosomiasisJ. Rodgers, I. Steiner, and P.G.E. Kennedy

Open Access

TABLE OF CONTENTS Volume 6, Number 6, November 2019 Neurology.org/NN

Academy OfficersJames C. Stevens, MD, FAAN, PresidentOrly Avitzur, MD, MBA, FAAN, President ElectAnn H. Tilton, MD, FAAN, Vice PresidentCarlayne E. Jackson, MD, FAAN, SecretaryJanis M. Miyasaki, MD, MEd, FRCPC, FAAN, TreasurerRalph L. Sacco, MD, MS, FAAN, Past President

Executive Office, American Academy of NeurologyCatherine M. Rydell, CAEChief Executive Officer201 Chicago AveMinneapolis, MN 55415Tel: 612-928-6100

Editorial OfficePatricia K. Baskin, MS, Executive EditorKathleen M. Pieper, Senior Managing Editor, NeurologySharon L. Quimby, Managing Editor, Neurology® Clinical PracticeMorgan S. Sorenson, Managing Editor, Neurology® Neuroimmunology& Neuroinflammation

Lee Ann Kleffman, Managing Editor, Neurology® GeneticsAndrea Rahkola, Production Editor, NeurologyRobert J. Witherow, Senior Editorial AssociateKaren Skaja, Senior Editorial AssociateKaitlyn Aman Ramm, Editorial AssistantKristen Swendsrud, Editorial AssistantJustin Daugherty, Editorial AssistantMadeleine Sendek, MPH, Editorial Assistant

PublisherWolters KluwerBaltimore, MD

Publishing StaffKim Jansen, Executive PublisherJessica Heise, Production Team Leader, Neurology JournalsMegen Miller, Production EditorStacy Drossner, Production Associate

Neurology® is a registered trademark of the American Academy of Neurology(registration valid in the United States).

Neurology® Neuroimmunology & Neuroinflammation (eISSN 2332-7812) is anopen access journal published online for the American Academy of Neurology,201 Chicago Ave, Minneapolis, MN 55415, by Wolters Kluwer Health, Inc. at14700 Citicorp Drive, Bldg 3, Hagerstown, MD 21742. Business offices arelocated at Two Commerce Square, 2001 Market St., Philadelphia, PA 19103.Production offices are located at 351 West Camden Street, Baltimore, MD21201-2436. © 2019 American Academy of Neurology.

Neurology® Neuroimmunology & Neuroinflammation is an official journal of theAmerican Academy of Neurology. Journal website: Neurology.org/NN, AANwebsite: AAN.com

Copyright and Permission Information: Please go to the journal website(www.neurology.org/nn) and click the Permissions tab for the relevant article.Alternatively, send an email to healthpermissions@wolterskluwer.com. Generalinformation about permissions can be found here: https://www.lww.com/journal-permission.

Disclaimer: Opinions expressed by the authors and advertisers are notnecessarily those of the American Academy of Neurology, its affiliates, or ofthe Publisher. The American Academy of Neurology, its affiliates, and thePublisher disclaim any liability to any party for the accuracy, completeness,efficacy, or availability of the material contained in this publication (includingdrug dosages) or for any damages arising out of the use or non-use of any of thematerial contained in this publication.

Advertising Sales Representatives: Wolters Kluwer, 333 Seventh Avenue, NewYork, NY 10001. Contacts: Eileen Henry, tel: 732-778-2261, fax: 973-215-2485,eileen.henry@wolterskluwer.com and in Europe: Craig Silver, tel: +44 7855062 550 or e-mail: craig.silver@wolterskluwer.com.

Careers & Events: Monique McLaughlin, Wolters Kluwer, Two CommerceSquare, 2001 Market Street, Philadelphia, PA 19103, tel: (215)-521- 8468, fax:215-521-8801; monique.mclaughlin@wolterskluwer.com.

Reprints: Meredith Edelman, Commercial Reprint Sales, Wolters Kluwer,Two Commerce Square, 2001 Market Street, Philadelphia, PA 19103, tel:215-356-2721; meredith.edelman@wolterskluwer.com; reprintsolutions@wolterskluwer.com.

Special projects: US & Canada: Alan Moore, Wolters Kluwer, Two CommerceSquare, 2001 Market Street, Philadelphia, PA 19103, tel: 215-521-8638,alan.moore@wolterskluwer.com. International: Andrew Wible, Senior Manager,Rights, Licensing, and Partnerships, Wolters Kluwer, translationrights@wolterskluwer.com.

Copyright © 2019 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.

A peer-reviewed clinical and translational neurology open access journal Neurology.org/NN

Neurology® Neuroimmunology & Neuroinflammation

EditorJosep O. Dalmau, MD, PhD

Deputy EditorScott S. Zamvil, MD, PhD, FAAN

Associate EditorsMarinos Dalakas, MD, FAANMichael Heneka, MDDennis Kolson, MD, PhDFriedmann Paul, MD

Editorial BoardRohit Aggarwal, MD, MSSergio E. Baranzini, PhDSusanne Benseler, MDJeffrey L. Bennett, MD, PhD, FAANSeverine Boillee, PhDMatthijs C. Brouwer, MD, PhDWolfgang Bruck, MDDavid B. Clifford, MD, FAANRussell C. Dale, MBChB, MRCP, PhDOscar H. Del Brutto, MD, FAANThomas G. Forsthuber, MDKazuo Fujihara, MDJeffrey M. Gelfand, MD, MAS, FAANJoseph El Khoury, MDMarkus P. Kummer, PhD

Jun Li, MD, PhDLin Mei, MD, PhDAndrew McKeon, MDChristopher Power, MDRichard M. Ransohoff, MDChristine Stadelmann, MDIsrael Steiner, MDLawrence Steinman, MDJesper Tegner, PhD, MScSilvia N. Tenembaum, MDMaarten J. Titulaer, MD, PhDAri Waisman, PhDHugh J. Willison, MBBS, PhDGregory F. Wu, MD, PhD

Neurology® Journals

Editor-in-ChiefRobert A. Gross, MD, PhD, FAAN

Deputy EditorBradford B. Worrall, MD, MSc, FAAN

Section Editors

BiostatisticsRichard J. Kryscio, PhDSue Leurgans, PhDV. Shane Pankratz, PhD

Classification of Evidence EvaluationsGary S. Gronseth, MD, FAAN

Equity, Diversity, and Inclusion (EDI)Roy H. Hamilton, MD, MS, FAANHolly E. Hinson, MD, MCR, FAAN

PodcastsStacey L. Clardy, MD, PhDJeffrey B. Ratliff, MD, Deputy Podcast Editor

OmbudsmanDavid S. Knopman, MD, FAAN

Scientific Integrity AdvisorRobert B. Daroff, MD, FAAN

Classification of Evidence Review TeamMelissa J. Armstrong, MDRichard L. Barbano, MD, PhD, FAANRichard M. Dubinsky, MD, MPH, FAANJeffrey J. Fletcher, MD, MScGary M. Franklin, MD, MPH, FAANDavid S. Gloss II, MD, MPH&TMJohn J. Halperin, MD, FAANJason Lazarou, MSc, MDSteven R. Messe, MD, FAANPushpa Narayanaswami, MBBS, DM, FAANAlex Rae-Grant, MD

Vision Neurology® Neuroimmunology &Neuroinflammation will be the premierpeer-reviewed journal in the fields ofneuroimmunology and neuroinflammation.

Mission Neurology: Neuroimmunology &Neuroinflammation will provide neurologistsand clinical research scientists withoutstanding peer-reviewed articles, editorials,and reviews to enhance patient care andfacilitate basic and translational research.

EditorialInquiries

Tel: 612-928-6400Toll-free: 800-957-3182 (US)Fax: 612-454-2748nnnjournal@neurology.org

StayConnected

facebook.com/NeurologyNN

twitter.com/greenjournal

youtube.com/user/NeurologyJournal

Copyright © 2019 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.

2019;6; Neurol Neuroimmunol Neuroinflamm 6 (6)

This information is current as of January 1, 2019

ServicesUpdated Information &

http://nn.neurology.org/content/6/6.full.htmlincluding high resolution figures, can be found at:

Supplementary Material http://nn.neurology.org/content/suppl/2019/11/08/6.6.DC1

Supplementary material can be found at:

  Permissions & Licensing

http://nn.neurology.org/misc/about.xhtml#permissionsits entirety can be found online at:Information about reproducing this article in parts (figures,tables) or in

  Reprints

http://nn.neurology.org/misc/addir.xhtml#reprintsusInformation about ordering reprints can be found online:

rights reserved. Online ISSN: 2332-7812.Published since April 2014, it is an open-access, online-only, continuous publication journal. Copyright . All

is an official journal of the American Academy of Neurology.Neurol Neuroimmunol Neuroinflamm